Cambridge Healthtech Institute’s Thirteenth Annual

Molecular Diagnostics

Guidelines for Success

March 7 – 9, 2016 | Moscone North Convention Center | San Francisco, CA
Part of the 23rd International Molecular Medicine Tri-Conference

 

Molecular diagnostics is poised for significant growth and is driving new markets. Efforts to standardize test development and demonstrate sufficient evidence of clinical utility are critical to the industry so that results can be interpreted reliably and confidently. Yet uncertainty remains around who will be developing guidelines and ensuring proper implementation in healthcare. The demand is growing by consumers, but safeguards need to be put in place and a concerted effort needs to be made to educate the various stakeholders. Join us at the industry leaders networking event to learn guidelines for successful implementation of diagnostics from experts in the field.

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Diagnostic and Medical Device companies, Large Pharma, Biotechs and Academia working in fields of Diagnostics, Business Development, R&D, Chemistry, Clinical Research, in vitro Diagnostics, Personalized Healthcare, Process Development, and Oncology.

Topics will include, but are not limited to:

  • The Second Annual Swimming with the Sharks competition for platform and molecular diagnostics companies seeking venture funding to pitch their company’s value proposition to a panel of judges
  • Guidelines to classify genomic variants
  • Design, validation, interpretation and compliance of NGS assays
  • Demonstration of clinical utility and value of molecular diagnostics
  • How to gain payer coverage
  • Explore patient pay models
  • Case studies of personalized medicine outside of oncology
  • Molecular diagnostics at the point-of-care
  • Updates on regulatory oversight of LDTs

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is August 28, 2015.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464
E: clingham@healthtech.com

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z)
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com

Premier Sponsors:  

Bina Technologies

Coyote

Elsevier   

Jackson Laboratory - small logo 

 NanoString2   

 Precision for Medicine 

SeraCare(2)

Silicon Biosystems

Thomson Reuters-Large